Life Science Venture Capital Funds have ballooned in size fueling investment in the industry
Over a decade ago, life science funds ranged from $100 to $350 million
July 03, 2019
- Over a decade a go, life science funds ranged from $100 to $350 million. Today, these funds typically bring in double if not triple that. Life Science investment firms, Third Rock Ventures, Flagship Pioneering, & Foresite Capital, have all recently raised record sized funds over $600 million in the last 24 months.
- While those three groups have all been mainstays to Kendall Square for over a decade, private investment behemoth Bain Capital has recently joined the fray. In 2017 they opened their first life science fund deploying over $720 million. Last month Bain announced a new $1.1 billion life science fund, the biggest ever for the area. They hope to invest in 15 to 20 companies committing $20 to $100 million to each.
- This funding bonanza will further drive demand for lab space in the area, as companies will be coming out of incubators with an infusion of capital looking to quickly scale into more research space.
You may also like
Shifts in the way people live, work and shop in a post pandemic world have forever impacted the industrial real estate sector
Chestnut and Walnut Street retail visits drop precipitously in Philadelphia during COVID-19 pandemic
Pressure from distressed New York retailers has softened landlord sentiment, allowing for lease restructurings